Meeting Register Page

Webinar on the updates of Wave's clinical trial SELECT-HD
Dr. Ralf Reilmann, founder of the George-Huntington Institute in Muenster, will be presenting an overview of the SELECT-HD trial, which is looking at the safety of the investigational molecule called WVE-003. After his presentation, Danlin Xu (HD Medical Director) and Marissa Volpe (HD Program Lead) will lead the Q&A session.
Meeting logo
* Required information